Pharmacogenetics to prevent maniac affective switching with treatment for bipolar disorder: CYP2D6

Written by Sánchez-Martín A, Sánchez-Iglesias S, García-Berrocal B, Lorenzo C, Gaedigk A, Isidoro-García M

Bipolar disorder (BPD), formerly known as manic depression, is a mental illness characterized by periods of depression and periods of mania/hypomania. The main symptoms such as depressed mood, insomnia, paranoid ideation, anxiety and appetite changes are shared with other psychiatric disorders. However, the phenomenon of switching, in other words, a sudden transition from a mood episode to another episode of the opposite polarity, is a critical difference between BPD and other psychiatric disorders [1]. Despite the importance of the switching phenomenon, the exact mechanisms leading to this process are still poorly understood although certain neurobiological factors have been associated with...

To view this content, please register now for access

It's completely free